Participants convened by the Campaign to Decriminalise Poverty and Status outline the harms of criminalisation for marginalised groups and call for urgent action to curb them through legal reforms, further research and funding for civil society.
IDPC addresses the tensions facing the INCB, and the global drug control regime as a whole, in relation to the increasing number of jurisdictions adopting legally regulated markets, and concludes on the need for reform and modernisation.
The Benzo Research Project summarises peer-led research on benzodiazepine use among young people in Britain, and makes recommendations to reduce related harms.
EHRA offers a resource to facilitate the analysis and collation of documented human rights violations, as well as their submission to international accountability bodies.
Celidwen et al. provide a framework to consider more respectful relationships between Western institutions and Indigenous psychedelic medicines, with a view to resist extraction and commercialisation.
Drugs, Habits and Social Policy dedicates a special issue to present some of the latest insights into this harm reduction practice and explore enduring limitations of the scientific literature to date.
Ivsins et al. find overwhelming participant support for these services whilst shedding light on the mediating influence of physical environments, social resources and various structural forces.
Craft et al. find no clear evidence that exposure to analytically confirmed synthetic cannabinoids increased or decreased after implementing the Psychoactive Substances Act 2016.
IDPC highlights how the increasing involvement of UN human rights entities in drug policy debates has paved the way for greater, yet still insufficient, consideration of health, human rights and development.
The publication offers insights into how the PARTY project organised and implemented online harm reduction interventions working with e-volunteers and harm reduction experts.
